ICAD INC. - COMMON STOCK

iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of Radiology

13 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

ProFound AI Risk Real-World Case Studies to be featured in iCAD’s “ProFound Insights, ProFound Impact” Webinar Series

29 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Highlight ProFound AI Risk

07 Jun 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD to Present at the JMP Securities Life Sciences Conference on June 15-16, 2022

06 Jun 2022 08:08:21 By Nasdaq GlobeNewswire

iCAD Announces CFO Transition

25 May 2022 08:01:43 By Nasdaq GlobeNewswire

New Real-World Evidence Shows ProFound AI Improves Cancer Detection and Accuracy with Digital Breast Tomosynthesis, or 3D Mammography

18 May 2022 08:00:01 By Nasdaq GlobeNewswire

New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk Models

16 May 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2022

11 May 2022 16:07:23 By Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology

28 Apr 2022 08:00:03 By Nasdaq GlobeNewswire

iCAD to Report First Quarter 2022 Financial Results on Wednesday, May 11

27 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems

26 Apr 2022 08:00:03 By Nasdaq GlobeNewswire

iCAD Announces Estimated Q1 Revenue and Upcoming Board and CFO Transitions

21 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD Launches ProFound Insights, ProFound Impact Webinar Series on April 27

19 Apr 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD Announces Additional Patients Treated Under GLIOX Trial and Continued Global Momentum for Xoft Intraoperative Radiation Therapy (IORT) for Brain, Rectal, Head and Neck Tumor Treatment

05 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

iCAD Showcases Innovative Breast Health Solutions Platform at National Consortium of Breast Centers (NCoBC) 31st Annual Conference

10 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference

09 Mar 2022 11:21:38 By Nasdaq GlobeNewswire

iCAD Among the First to Validate its AI Cancer Detection Solutions with the NVIDIA AI Enterprise Software Suite

02 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

iCAD to Present at the 42nd Annual Cowen Health Care Conference

01 Mar 2022 08:00:03 By Nasdaq GlobeNewswire

iCAD Reports Financial Results for Fourth Quarter and Year Ended December 31, 2021

28 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

14 Feb 2022 16:05:00 By Nasdaq GlobeNewswire